arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI

$6.95 ▼ -0.73 (-9.51%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

MARAVAI LIFESCIENCES HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0B

Dividend Yield —

Revenue Growth -28.3% ↘

Op. Margin -115.9% ↘

ROIC -41.9% ↘

FCF / Share $-0.49 ↘

Trailing P/E —

Price / Book 4.7x

FCF Yield —

Debt / Equity 1.37

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$185.74M

↓ -28.3% —

Net Income Profit after all expenses

$-130.77M

↑ +9.7% —

Operating Margin Operating profit as % of sales

-115.9%

↓ -27.5% 2th

FCF / Share Free cash flow per share

$-0.49

↓ -204.4% —

Long-Term Debt Long-term obligations

$291.77M

↓ -1.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-28.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-454%)	-10.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-229%)	-67.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-941%)	10.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31%)	181.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2167%)	98.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1131%)	—
EPS Growth YoY (%)	14.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-16.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	5.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-78.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—
Net Income Growth YoY (%)	9.7% Fair ↑ Fair Improving Year-over-year change in net income	-21.7% Weak ↓ Weak Declining Year-over-year change in net income	N/M	21.0% Good Good Year-over-year change in net income	104.6% Excellent Excellent Year-over-year change in net income	N/M	—
FCF Growth YoY (%)	-204.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	N/M	-88.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	28.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	-74.8% Weak Weak Year-over-year change in free cash flow	44538.6% Excellent Excellent Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	-40.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-31.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.6% Weak Weak Compound annual revenue growth over 3 years	83.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	-8.1% Weak Weak Compound annual revenue growth over 5 years	12.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-115.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-873%)	-90.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-706%)	-11.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-173%)	65.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+334%)	69.4% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+363%)	42.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+181%)	16.8% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+12%)
Effective Tax Rate (%) (%)	1.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	122.4% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-70.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-687%)	-55.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-566%)	-41.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-443%)	24.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+108%)	22.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+90%)	31.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+161%)	-3.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-126%)
FCF Margin (%) (%)	-38.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-8.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.0% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	58.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	44.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	44.6% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	4.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.36x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.94x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.42x Good Good Free cash flow relative to reported net income Optimal: > 1x	-1.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-41.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	47.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	58.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	23.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-27.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	25.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	28.9% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	9.4% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-61.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-44.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-397%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	40.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+169%)	57.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+285%)	100.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+570%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	1.37x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+129%)	0.91x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+52%)	1.26x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+110%)	0.97x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+61%)	1.68x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+180%)	4.52x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+653%)	—
Interest Coverage (x)	-8.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.69x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	28.13x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	18.33x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	3.90x Fair Fair Operating income divided by interest expense Optimal: > 5x	0.80x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$74.88M	$-26.47M	$-50.81M	$-104.70M	$530.59M	$400.00M	—
Debt / EBITDA (x)	-1.52x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.38x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-27.95x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.91x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.95x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.19x Caution Caution Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$1.29	$1.88	$2.19	$6.71	$6.96	$27.45	$0.56
Basic EPS, GAAP (USD)	$-0.90	$-1.05	$-0.90	$1.67	$1.59	$7.43	$-0.03
Free Cash Flow per Share (USD)	$-0.49	$-0.16	$0.46	$3.94	$3.08	$12.25	$0.03
Book Value per Share (USD)	$1.47	$2.36	$3.16	$4.14	$2.75	$8.55	—
Tangible Book Value per Share (USD)	$-0.48	$-0.21	$-0.99	$0.34	$0.39	$-30.28	—
Basic Weighted Avg Shares (shares)	144.36M	137.91M	131.92M	131.54M	114.79M	10.35M	253.92M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$251.33M	$372.18M	$612.44M	$737.76M	$646.26M	$200.82M	—
LT Debt (USD)	$291.77M	$295.93M	$524.15M	$527.44M	$530.59M	$400.00M	—
Total Equity (USD)	$212.38M	$325.29M	$416.75M	$545.22M	$315.50M	$88.51M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$185.74M	$259.19M	$288.94M	$883.00M	$799.24M	$284.10M	$143.14M
Depreciation Expense (USD)	$23.56M	$20.85M	$12.90M	$7.57M	$6.41M	$5.59M	$3.81M
Net Income, GAAP (USD)	$-130.77M	$-144.85M	$-119.03M	$220.21M	$182.04M	$88.97M	$-4.47M
Operating Cash Flow (USD)	$-57.57M	$7.46M	$126.22M	$535.98M	$368.57M	$152.19M	$24.11M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 26 quarters

MARAVAI LIFESCIENCES HOLDINGS, INC.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MRVI with peers